You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 4,992,474


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,992,474
Title: Phenethanolamine derivatives
Abstract:Phenethanolamine derivatives are disclosed of formula ##STR1## wherein m is 2 to 8; n is 1 to 7 provided that m+n is 4 to 12; Ar is phenyl or phenyl substituted by one or two halogen atoms, alkyl or alkoxy groups or by an alkylenedioxy group; R.sup.1 and R.sup.2 are hydrogen or alkyl provided that the sum total of carbon atoms in R.sup.1 and R.sup.2 is not more than 4; and the physiologically acceptable salts and solvates thereof. The compounds have a selective stimulant action at .beta..sub.2 -adrenoreceptors and may be used inter alia in the treatment of diseases associated with reversible airways obstructions such as asthma and chronic bronchitis. The compounds may be formulated in conventional manner as pharmaceutical compositions with physiologically acceptable carriers or excipients. The compounds may be prepared, for example by alkylation of an amine: ##STR2## where R.sup.3, R.sup.5 and R.sup.6 is hydrogen or a protecting group, followed by removal of any protecting group.
Inventor(s): Skidmore; Ian F. (Welwyn, GB2), Lunts; Lawrence H. C. (Broxbourne, GB2), Finch; Harry (Hitchin, GB2), Naylor; Alan (Royston, GB2)
Assignee: Glaxo Group Ltd. (London, GB2)
Application Number:07/397,664
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,992,474

Introduction

United States Patent 4,992,474, though not as widely discussed in recent patent analyses, is an important example of how patent scope and claims are defined and evaluated. This article will delve into the details of this patent, exploring its claims, the broader patent landscape, and the criteria that define its validity and impact.

Patent Overview

United States Patent 4,992,474 was granted for a specific chemical compound and its preparation method. Here is a brief overview of the patent:

  • Title and Subject Matter: The patent pertains to the preparation of a particular chemical compound, specifically the R enantiomer of a certain molecule.
  • Grant Date: The patent was granted after a thorough examination process, which involves assessing the novelty, nonobviousness, and utility of the invention[4].

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of protection. For US Patent 4,992,474:

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. They typically describe the core elements of the invention without referencing other claims.
  • Dependent Claims: These claims build upon the independent claims, adding additional limitations to narrow the scope. They are used to provide further detail and protect specific aspects of the invention[3].

Claim Length and Count

Research has shown that the length and count of independent claims can influence the patent's scope and the likelihood of grant. Narrower claims, as measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process[3].

Patent Scope

Metrics for Measuring Scope

The scope of a patent is crucial in determining its impact and validity. Here are some metrics used to measure patent scope:

  • Independent Claim Length: Longer independent claims often indicate broader scope, but they can also increase the complexity and reduce the clarity of the claims.
  • Independent Claim Count: A higher number of independent claims can broaden the patent's scope but may also increase the risk of rejection due to lack of clarity or overbreadth[3].

Patent Maintenance Payments and Forward Citations

  • Patent Maintenance Payments: These payments are required to keep the patent in force. Higher maintenance payments are often associated with patents that have a broader scope and greater economic value.
  • Forward Citations: The number of times a patent is cited by later patents can indicate its influence and scope. Patents with narrower claims at publication tend to have more forward citations, suggesting a clearer and more focused invention[3].

Patent Landscape

Technology Fields

The USPTO categorizes patents into various technology fields. For chemical compounds like those in US Patent 4,992,474, the relevant field would be "Chemical" or "Drugs and Medical Instruments"[1].

Allowance Rates

The probability of receiving a patent varies significantly across different technology fields. For example, applications in the "Drugs and Medical Instruments" field have seen a substantial decrease in allowance rates over time, reflecting increased scrutiny and higher standards for patentability[1].

Patentability Requirements

To be granted, an invention must meet several criteria:

  • Utility: The invention must be operable and provide some tangible benefit.
  • Novelty: The invention must not be fully anticipated by prior art.
  • Nonobviousness: The invention must not be readily within the ordinary skills of a competent artisan at the time it was made[4].

Examination Process

The examination process for patents involves several stages:

  • First-Action Allowance Rate: The proportion of applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of applications that produce at least one patent, including outcomes of continuation applications[1].

Continuation Procedures

Continuation procedures are often used to address issues raised during the examination process. These include:

  • Requests for Continued Examination (RCEs): These allow applicants to continue the examination process after receiving a non-final rejection.
  • Serialized and Non-Serialized Continuations: These procedures help applicants to refine their applications and address examiner objections[1].

Impact on Innovation

The scope and claims of a patent like US 4,992,474 can significantly impact innovation:

  • Licensing and Litigation Costs: Overly broad patents can increase licensing and litigation costs, potentially diminishing incentives for innovation.
  • Clear and Focused Claims: Patents with narrower, clearer claims tend to facilitate innovation by providing clear boundaries and reducing legal disputes[3].

Key Takeaways

  • Patent Claims: The scope of a patent is defined by its claims, with independent claims being crucial for determining the broadest scope of protection.
  • Patent Scope Metrics: Metrics such as independent claim length and count can help measure the scope and predict the success of a patent application.
  • Patentability Requirements: Inventions must meet utility, novelty, and nonobviousness criteria to be granted.
  • Examination Process: The examination process involves multiple stages, including first-action allowance, progenitor allowance, and family allowance rates.
  • Continuation Procedures: These procedures are essential for addressing issues during the examination process.

FAQs

  1. What are the key criteria for patentability in the United States?

    • To be patentable, an invention must be useful, novel, and nonobvious, and it must claim patentable subject matter[4].
  2. How do continuation procedures affect the patent examination process?

    • Continuation procedures, such as Requests for Continued Examination (RCEs), allow applicants to continue the examination process after receiving a non-final rejection, helping to address examiner objections and refine the application[1].
  3. What is the significance of independent claim length and count in patent scope?

    • Narrower independent claims, as measured by length and count, are associated with a higher probability of grant and a shorter examination process. They also tend to have more forward citations, indicating clearer and more focused inventions[3].
  4. How have allowance rates changed over time for different technology fields?

    • Allowance rates have decreased substantially over time, particularly for applications in the “Drugs and Medical Instruments” and “Computers and Communications” fields[1].
  5. What role does the USPTO play in the patent system?

    • The USPTO is responsible for examining applications and granting patents on inventions when applicants are entitled to them. It also publishes and disseminates patent information and maintains search files of U.S. and foreign patents[4].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. PubChem. (n.d.). Pharmaceutical aerosol formulation - Patent US-7090831-B1.
  3. SSRN. (2016). Patent Claims and Patent Scope.
  4. CRS Reports. (2022). Patents and Innovation Policy.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,992,474

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,992,474

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8310477Apr 18, 1983
United Kingdom8317087Jun 23, 1983
United Kingdom8329568Nov 04, 1983
United Kingdom8401889Jan 25, 1984

International Family Members for US Patent 4,992,474

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 244199 ⤷  Subscribe
Argentina 245687 ⤷  Subscribe
Argentina 247721 ⤷  Subscribe
Austria 390611 ⤷  Subscribe
Austria A129184 ⤷  Subscribe
Australia 2706484 ⤷  Subscribe
Australia 573212 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.